4.6 Article

Impaired long-term depression in schizophrenia: A cathodal tDCS pilot study

期刊

BRAIN STIMULATION
卷 5, 期 4, 页码 475-483

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.brs.2011.08.004

关键词

schizophrenia; long-term depression; cortical plasticity; transcranial direct current stimulation; glutamate; transcranial magnetic stimulation

资金

  1. Deutsche Forschungsgemeinschaft (DFG) [HA 6091/1-1, NI 683/6-1, FA 241/10-1]
  2. Janssen-Cilag
  3. Astrac-Zeneca
  4. Lilly
  5. BMS
  6. Lundbeck
  7. Pfizer
  8. Bayer Vital
  9. SKB
  10. Wyeth
  11. Essex
  12. Alpine Biomed
  13. AstraZeneca
  14. Bristol Myers Squibb
  15. Eli Lilly
  16. Sanofi-Aventis

向作者/读者索取更多资源

Background Neural plasticity involves the reorganization of synaptic connections and represents the ability of the brain to adjust its function in response to challenge. Disturbed cortical plasticity has been linked to the pathophysiology of schizophrenia, with indirect evidence for disturbed plasticity in the disease state having been provided by postmortem studies and various animal models. However, glutamate-dependent long-term depression (LTD)-like cortical plasticity has not yet been investigated. Objective To investigate LTD-like cortical plasticity after transcranial direct current stimulation (tDCS) in schizophrenia patients. Methods Using excitability-diminishing cathodal tDCS, we performed the first in vivo assessment of glutamate-dependent LTD-like cortical plasticity in 21 schizophrenia patients and 21 matched healthy control subjects. To reveal the physiologic basis of the hypothesized plasticity deficits, we tested different inhibitory and excitatory neuronal circuits with transcranial magnetic stimulation (TMS). Results Cathodal tDCS failed to reduce motor-evoked potential amplitudes in schizophrenia patients, indicating abolished LTD-like plasticity. Furthermore, schizophrenia patients had a prolonged GABA(B)-dependent cortical silent period (CSP) at baseline and tDCS failed to modulate the duration of CSP in the patient group. Finally, schizophrenia patients presented an elevated resting-motor threshold at baseline in comparison to healthy controls. Conclusions The pattern of our results provides evidence for a specific plasticity deficit in schizophrenia patients, which might be associated with a hyperglutamatergic state. These findings may reflect a reduced signal-to-noise ratio and a disturbed filter function in schizophrenia patients. An increase of GABA(B)-activity may be a compensatory mechanism to dysfunctional LTD-like plasticity in schizophrenia. (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据